PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
63.91%
Revenue growth under 50% of MTDR's 223.25%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
467.26%
Gross profit growth above 1.5x MTDR's 147.46%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
62.90%
EBIT growth 1.25-1.5x MTDR's 49.20%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
62.90%
Operating income growth 1.25-1.5x MTDR's 49.20%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
65.30%
Net income growth above 1.5x MTDR's 21.89%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
65.32%
EPS growth above 1.5x MTDR's 21.71%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
65.32%
Diluted EPS growth above 1.5x MTDR's 21.71%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.00%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
321.37%
OCF growth above 1.5x MTDR's 8.48%. David Dodd would confirm a clear edge in underlying cash generation.
205.19%
FCF growth above 1.5x MTDR's 12.88%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-72.18%
Negative 10Y revenue/share CAGR while MTDR stands at 639.30%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-41.29%
Negative 5Y CAGR while MTDR stands at 50.80%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
3.54%
3Y revenue/share CAGR under 50% of MTDR's 39.36%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-78.91%
Negative 10Y OCF/share CAGR while MTDR stands at 410.86%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-29.56%
Negative 5Y OCF/share CAGR while MTDR is at 10.23%. Joel Greenblatt would question the firm’s operational model or cost structure.
3.45%
Positive 3Y OCF/share CAGR while MTDR is negative. John Neff might see a big short-term edge in operational efficiency.
-242.27%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
20.35%
5Y net income/share CAGR 1.25-1.5x MTDR's 16.78%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
-487.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-85.78%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-58.07%
Negative 5Y equity/share growth while MTDR is at 39.86%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-53.19%
Negative 3Y equity/share growth while MTDR is at 31.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-90.75%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-59.12%
Negative 5Y dividend/share CAGR while MTDR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
28.42%
3Y dividend/share CAGR of 28.42% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-6.53%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-9.75%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-25.90%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-2.85%
We’re deleveraging while MTDR stands at 5.55%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-16.70%
We cut SG&A while MTDR invests at 2.56%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.